NASDAQ:INKT | Cash Flow Statement | MiNK Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.13M
2026-03-31-$2.74M-$1.73M-$2.1M
2025-12-31-$2.6M-$2.07M$1.18M
2025-09-30-$2.89M
2025-06-30-$4.24M
2025-03-31-$2.77M-$1.34M$576.00
2024-12-31-$2.46M-$1.73M-$3.00
2024-09-30-$1.81M
2024-06-30-$2.7M
2024-03-31-$3.81M-$2.54M$5.01M
2023-12-31-$5.46M-$3.04M$0.00$0.00-$2.00
2023-09-30-$5.12M
2023-06-30-$6.2M
2023-03-31-$5.69M-$4.37M$13,500.00-$13,500.00-$334,425.00
2022-12-31-$7.77M-$4.43M$127,838.00-$127,838.00$111.00
2022-09-30-$6.33M
2022-06-30-$6.11M
2022-03-31-$7.78M-$4.2M$689.00
2021-12-31-$5.76M-$1.7M-$277.00$277.00$39.8M
2021-09-30-$14.27M
2021-06-30-$6.34M
2021-03-31-$3.85M-$4.21M$39,520.00-$39,520.00$2.32M
2020-12-31-$1.54M-$1.72M$0.00$0.00$3.33M
2020-09-30-$6.04M
2020-06-30-$4.27M
2020-03-31-$4.39M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$12.49M-$5.93M$14.72M
2024-12-31-$10.78M-$9.56M$10.82M
2023-12-31-$22.46M-$15.76M$73,561.00-$73,561.00-$407,173.00
2022-12-31-$27.99M-$18.87M$250,046.00-$250,046.00-$155,599.00
2021-12-31-$30.21M-$12.83M$248,983.00-$248,983.00$49.26M
2020-12-31-$16.24M-$8.34M$95,212.00-$95,212.00$11.11M